Publications

5891 Results

Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group study

Authors
SG Urba;K Chansky;PJ vanVeldhuizen;RE Pluenneke;JK Benedetti;JS Macdonald;JL Abbruzzese
Journal / Conference
Investigational New Drugs 22:91-97
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
S9801

Randomized phase II trial of two high dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

Authors
PJ Stiff;EJ Shpall;PY Liu;SP Wilczynski;NS Callander;SA Scudder;AR Jazieh;W Samlowski;J McCoy;DS Alberts
Journal / Conference
Gynecologic Oncology 94:98-106
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9106

Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukemia

Authors
DL Stirewalt;S Meshinchi;SJ Kussick;KM Sheets;E Pogosova-Agadjanyan;CL Willman;JP Radich
Journal / Conference
British Journal of Haematology 124:481-484
Year
2004
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Adjuvant therapy of osteosarcoma, a phase II trial Southwest Oncology Group study 9139

Authors
MM Zalupski;C Rankin;JR Ryan;DR Lucas;J Muler;KS Lanier;GT Budd;JS Biermann;FJ Meyers;K Antman
Journal / Conference
Cancer 100(4):818-825
Year
2004
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9139

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

Authors
RP Whitehead;JK Benedetti;JL Abbruzzese;B Ardalan;S Williamson;ER Gaynor;SP Balcerzak;JS Macdonald
Journal / Conference
Investigational New Drugs 22:467-473
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9107

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

Authors
RS Lavey;PY Liu;BE Greer;WR Robinson;PC Chang;RB Wynn;ME Conrad;C Jiang;M Markman;DS Alberts
Journal / Conference
Gynecologic Oncology 95:145-151
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9318, SWOG-9405

Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group

Authors
DS Alberts;C Jiang;PY Liu;SP Wilcynski;M Markman;ML Rothenberg
Journal / Conference
International Journal of Gynecologic Cancer 14:224-228
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9326

Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the leukemia and lymphoma molecular profiling project

Authors
L Rimsza;RA Roberts;TP MIller;JM Unger;M LeBlanc;R Braziel;DD Weisenburger;WC Chan;K Muller-Hermelink;ES Jaffe;RD Gascoyne;E Campo;D Fuchs;CM Spier;RI FIsher;J Delabie;A Rosenwald;LM Staudt;T Grogan
Journal / Conference
Blood 103(11):4251-4258
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer

Authors
GH Lyman;SJ Green;PM Ravdin;CE Geyer Jr;CA Russell;SP Balcerzak;GT Budd;S Martino
Journal / Conference
Breast Cancer Research and Treatment 85:143-150
Year
2004
Research Committee(s)
Breast
Study Number(s)
SWOG-9520

Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713

Authors
MJ Edelman;K Chansky;LE Gaspar;B Leigh;GR Weiss;SA Taylor;J Crowley;R Livingston;DR Gandara
Journal / Conference
Journal of Clinical Oncology 22(1):127-132
Year
2004
Research Committee(s)
Lung
Study Number(s)
S9713